Lauren Cohn

Lauren Cohn, MD, is a Professor of Medicine at Yale School of Medicine, specializing in Pulmonary, Critical Care and Sleep Medicine. She serves as Co-Director of the Yale Center for Asthma and Airway Diseases and Director of Biologics and Advanced Therapeutics for Airway Diseases at VA Connecticut Healthcare System. Her career spans clinical practice, research, and leadership in asthma and COPD.

• Education: MD, University of Minnesota (1987); BA in Biology, Smith College (1982); Post-Doctoral Fellow, Yale (1995); Fellow, Columbia-Presbyterian (1993)

Dr. Cohn's research focuses on airway immunology, particularly T2 cytokine pathways and biologic therapies for severe asthma. Her work bridges translational immunology and clinical trials, with recent studies on dupilumab and airway metaplasia.

Key trends in her publications include biomarker discovery in asthma, COVID-19 respiratory outcomes, and targeted therapies like CCL22-CCR4 pathway inhibitors. Collaborative work with teams at Yale and VA emphasizes interdisciplinary approaches.

Scientific Awards:

• Alumni Achievement Award, Sarnoff Foundation (2018)
• Research Core Center Pilot Funding, Yale Rheumatic Diseases (2009)
• Career Investigator Award, American Lung Association (2004)
• NIH Award (declined), Cystic Fibrosis Foundation (2000)
• Mentored Clinical Scientist Award, NIH/NHLBI (1998)

As an active clinical researcher, Dr. Cohn leads trials like NIMBLE and CHRONICLE, while advising on asthma biologics for Pieris and other pharmaceutical companies. Her Cohn Lab investigates epithelial-mesenchymal interactions in lung diseases.